Related Experiment Video
Updated: Apr 29, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
11.1K
Contemporary Concise Review 2024: Chronic Obstructive Pulmonary Disease.
Sarita Thawanaphong1,2,3, Parameswaran Nair1,2
1Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Respirology (Carlton, Vic.)
|May 28, 2025
Summary
Non-smoking COPD, prevalent in low-income countries, presents unique challenges. Early detection and targeted therapies like Dupilumab show promise, alongside crucial smoking cessation strategies and comorbidity management for better patient outcomes.
Area of Science:
- Pulmonology and Environmental Health
- Pharmacology and Therapeutics
Background:
- Non-smoking COPD is a significant health issue in low- and middle-income countries (LMICs), particularly affecting women, with biomass fuel exposure and air pollution as key risk factors.
- The eosinophilic endotype of COPD is a distinct biological profile, differing from asthma.
- Early detection of COPD can be enhanced through methods like PRISm, FEV1/FVC Z-scores, and quantitative CT imaging.
Purpose of the Study:
- To review current understanding and management strategies for non-smoking COPD.
- To explore novel therapeutic approaches and diagnostic tools for COPD.
- To emphasize the importance of integrated care, including smoking cessation and comorbidity management.
Main Methods:
- Literature review and synthesis of recent research findings on COPD pathophysiology, diagnosis, and treatment.
- Analysis of clinical trial data for targeted therapies like Dupilumab.
- Discussion of pharmacotherapy options for smoking cessation and management of related conditions.
Main Results:
- Dupilumab demonstrated efficacy in reducing exacerbations and improving lung function in COPD patients with elevated blood eosinophil counts (≥300 cells/μL).
- Biomarkers and imaging techniques offer improved early COPD detection.
- Pharmacotherapies such as cytisine and varenicline are effective for smoking cessation, while e-cigarettes raise safety concerns.
- Addressing mood disorders, dysfunctional breathing, and comorbidities (cardiovascular risk, obesity, sleep-disordered breathing) improves COPD management.
Conclusions:
- Targeted therapies and advanced diagnostic methods are advancing COPD care, especially for non-smoking populations.
- Smoking cessation remains a cornerstone of COPD management, with various pharmacotherapy options available.
- Holistic patient care, encompassing mental health and comorbidity management, is essential for improving quality of life in COPD patients.
Keywords:
COPD investigationsCOPD treatmentairway inflammationnon‐smoking COPDrecent advances in COPDMore Related Videos
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
3.0K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.4K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.4K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:23Chronic Obstructive Pulmonary Disease I: Introduction
31
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
31
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
27
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...
27